Notícias e Atividades da Otsuka Pharmaceutical

A Otsuka Pharmaceutical pertence à Otsuka Holdings.

Otsuka Holdings é uma das ...

• Forbes Global 2000 (#654);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings é uma empresa listada sob o símbolo 4578 (JP).

Otsuka Holdings tem presença direta em 11 países.

Otsuka Holdings possui 23 subsidiárias incluindo Araris Biotech, Cambridge Isotope Laboratories e Interpharma.

Eles estão dentro:

• Farmacêutica46%
• Equipamentos Médicos29%
• Outro25%

Fusão, aquisição e financiamento envolvendo Otsuka Holdings.

• Otsuka Pharmaceutical has announced the acquisition of Jnana Therapeutics  (publicado em 1 de agosto de 2024).

Veja o organograma con seus 175 executivos principais

Biografias mais buscadas da Otsuka Pharmaceutical

• Makoto Inoue, President and Representative Director
• Hiroshi Sugawara, Board Member
• Tatsuo Higuchi, Chairman and Representative Director

Recentes movimentos de executivos em Otsuka Pharmaceutical

• Hiroaki Ono antes Executive Managing Director of Pharmaceutical Business & Director, foi promovido a Senior Executive Managing Director and Director  (Notícia publicada em 22 de maio de 2026).

Criar um alerta
para seguir os movimentos de executivos da Otsuka Pharmaceutical.

Otsuka Holdings possui 1.913 concorrentes concorrentes Sanofi (França), Eli Lilly (Estados Unidos) e Moderna (Estados Unidos).

Popular M&A news in Farmacêutica

• Contraline acaba de anunciar uma arrecadação de fundos de 93 milhões de dólares. (publicado em 3 de junho de 2026).
• Hims & Hers adquiriu Eucalyptus (publicado em 2 de junho de 2026).
• Apotex preencheu seu dossiê de IPO. Seu símbolo de ação será TSX. (publicado em 2 de junho de 2026).

Outros contatos sugeridos na indústria do Farmacêutica

• Joaquin Duato - Chief Executive Officer and Chairman of the Board da Johnson & Johnson
• Richard Saynor - Chief Executive Officer da Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board da Abbott

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Otsuka Pharmaceutical

• Otsuka Signs Joint Research Agreement with Keio UniversityIndustry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan ｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy SupplementsFacilitating the Research and Development of Gummy Products｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Opens First POCARI SWEAT Factory in VietnamSupporting Health and Meeting Growing Demand｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical is Focusing on "Water, Nutrition, and Oxygen" to Tap into Human PotentialProvide "Wellness Energy" at Expo 2025 in Osaka, Kansai, Japan｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical is Expanding "Local Production and Local Recycling" of PET Bottle Initiatives in Cooperation with Local CommunitiesAgreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottle｜New
• HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Is Now on Sale - Insurance coverage begins on March 1, 2025｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Sponsor TOKYO MARATHON 2025 Supporting the Conditioning of Runners Worldwide with the Global Brand POCARI SWEAT｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Holdings Receives Award by the Commissioner of the Consumer Affairs Agency at FY2024 Award for Good Practices of Consumer-Oriented Management　- Recognized for Otsuka Pharmaceutical’s Longstanding Efforts to Prevent Heat Disorders- | Otsuka Group Ne
• View more press releases Close

Redes sociais sobre Otsuka Pharmaceutical

• Otsuka Pharmaceutical na Wikipedia, Google News e Yahoo Finance
• Otsuka Pharmaceutical na LinkedIn, X (Twitter) e YouTube